horizon3

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Investment Committee Member Dr Tam Nguyen. In this episode Tam talks to Michelle Gallaher from Opyl and Dr Stefan Harrer from Digital Health CRC,

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Megan Baldwin, CEO and Managing Director of Opthea Limited and Daniel Sharp, Corporate Financier in the Biotech sector.

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by John Melki CEO of Genetic Signatures, Dr Paul Gavin of Avecho and Michael Woods.

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm, and Dirk van Dissel Founder of Candour Advisory.

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Simon Davidson from Lander & Rogers and Deborah Rathjen from Carina Biotech.

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of MST Financial and Ralph Highnam of Volpara Health Technologies.

Episode – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue MacLennan a Senior Biotechnology and Medical Technology Executive.

Episode 6 – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to discuss healthcare investment and the outlook for 2021. Malcolm McColl, CEO & Co-Founder of ImmVirX will also join the panel to discuss his experience at Viralytics and what he is […]

Episode 5 – Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at Horizon 3 Biotech speaks to Dr Nina Webster, Dimerix Ltd CEO & MD Dr Matthijs Smith, Crucible Investments Pty Ltd Director.

Contact

Email your message to H3 Healthcare